One day wonder: Fast resolution of macular edema following intravitreal ranibizumab in retinal venous occlusions.
Indian J Ophthalmol
;
2013 Sep; 61(9): 528-530
Article
Dans Anglais
| IMSEAR
| ID: sea-155408
ABSTRACT
Macular edema is a significant cause of vision loss in patients with central retinal vein occlusions and branch retinal vein occlusions. Vascular endothelial growth factor (VEGF) appears to be a key factor in the pathogenesis of this disease. Anti‑VEGF therapy, such as intravitreal ranibizumab provides an effective treatment against vision‑threatening macular edema. We report three patients of retinal vein occlusion with macular edema who demonstrated overnight resolution of macular edema following treatment with intravitreal ranibizumab (0.5 mg). 3D optical coherence tomography (Optovue) was used as a tool for comparison of the macular thickness before and after treatment. The significant reductions in the central foveal thickness demonstrated in these patients one night after intravitreal injections could have significant influence on modifying current treatment protocols. Early treatment of macular edema related to retinal venous occlusive disease with anti‑VEGF injections could result in faster visual rehabilitation in these patients.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Type d'étude:
Guide de pratique
langue:
Anglais
Texte intégral:
Indian J Ophthalmol
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS